TITLE

Antiviral agent reduced cytomegalovirus disease after HSCT

PUB. DATE
October 2013
SOURCE
Hem/Onc Today;10/25/2013, Vol. 14 Issue 20, p46
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article presents the results of a randomized study as of late October 2013, which showed that patients who underwent hematopoietic stem cell transplantation were less likely to contract cytomegalovirus diseases when treated with higher doses of the antiviral agent brincidofovir.
ACCESSION #
91817890

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics